Eventide Healthcare & Life Sciences Fund CLASS I SHARES (ETIHX)

22.88
Net Asset Value
-1.42%
1 Day
+8.69%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.50%
Expense Ratio
--
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It is non-diversified.

Performance

1 month+4.05% 3 years--
3 months+18.80% 5 years--
1 year+14.74% Since inception+44.57%
Data through --

Peer Comparisonvs. Health

 ETIHXCategory
Performance 5-yr return--+21.57%
Expense ratio1.50%1.45%
Risk 5 year sharpe ratio--1.48
Net assets$164.3M$3.4B
Average market cap$1.4B$35.3B
Average P/E--26.2
Portfolio turnover33%33%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyEventide Funds
Fund manager & tenureFinny Kuruvilla / 2 Years
Minimal initial investment$100,000.00
Minimum IRA investment--

Holdings

U.S. stock95.61%
International stock2.34%
Cash2.05%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AGIO Agios Pharmaceuticals Inc4.37%
MDVN Medivation Inc3.89%
DYAX Dyax Corp2.91%
TTPH Tetraphase Pharmaceuticals Inc2.84%
RARE Ultragenyx Pharmaceutical Inc2.82%
CMRX Chimerix Inc2.79%
BLUE bluebird bio Inc2.62%
ABBV AbbVie2.57%
CELG Celgene2.34%
VCYT Veracyte Inc2.22%

To view my watchlist

Not a member yet?

Sign up now for a free account